Back to search
FDAFDA · Food and drugs·Recall number D-0322-2018

All sterile drug preparations remaining within expiry prepared from Morphine Sulfate PF Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.

Published February 14, 2018 · Recall initiated: November 30, 2017

Summary

FDA records drug Class II recall D-0322-2018, published February 14, 2018 and initiated November 30, 2017. Recalling firm: Intrathecal Compounding Specialist, LLC; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry (BUD between November 15, 2017 and December 16, 2017). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Intrathecal Compounding Specialist, LLC
Distributor
Nationwide
Lot
All lots remaining within expiry (BUD between November 15, 2017 and December 16, 2017).
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was All sterile drug preparations remaining within expiry prepared from Morphine Sulfate PF Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583. recalled?

Yes. FDA published recall D-0322-2018 on February 14, 2018. Reported hazard: Lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter